Karen Schroeder

Title: Innovations by Inventor Karen Schroeder in Decoding Spiking Cell Activity

Introduction

Karen Schroeder is an innovative inventor based in San Diego, CA, recognized for her contributions to the understanding of neural activity through her patented systems and methods. With her expertise in decoding observed spike counts for spiking cells, Schroeder's work plays a significant role in advancing the field of neuroscience.

Latest Patents

Karen Schroeder holds a patent for "Systems, methods, and media for decoding observed spike counts for spiking cells." This patent involves mechanisms that include receiving a first set of observed spike counts (FSoOSCs) for the spiking cells and determining a set of probabilities (SoPs) by retrieving or calculating these probabilities based on stored information (SI). The SI pertains to possible biological states (BSs) of a subject, with each BS belonging to one of several time sequences (PoTSs) indicative of potential actions of the subject. By employing a hardware processor, Schroeder can identify the first identified BS of the subject based on the FSoOSCs and the set of probabilities. This information ultimately assists in determining an action to be performed based on the identified biological state.

Career Highlights

Karen Schroeder currently works at Columbia University in the City of New York, where she continues to push the boundaries of neural research. Her patent highlights her dedication to exploring the complexities of spiking cells, providing a platform for enhanced understanding of neural encoding and potential applications in medical science.

Collaborations

Throughout her career, Schroeder has collaborated with esteemed colleagues such as Sean C. Perkins and Mark M. Churchland. Their collective efforts contribute significantly to the development of innovative solutions in neuroscience, fostering advancements that benefit both academic research and practical applications.

Conclusion

Karen Schroeder's inventive work exemplifies the importance of innovation in the field of neuroscience. With her patent and ongoing research at Columbia University, she is making strides towards understanding the enigmatic workings of biological systems, with potential impacts that could transform therapeutic approaches in the medical field.